Skip to main content
FinSpry Logo
FinSpry
HLN logo
HLN
(NYSE)
Haleon plc
$9.71-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Haleon (HLN) Stock Price & Financial Analysis

Haleon Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$9.63 - $9.74
52-Week High$11.28
52-Week Low$8.65
Open$9.68
Volume9.03M
Average Volume (3M)9.42M
Market Cap43.51B
Shares Outstanding4.48B
P/E Ratio (TTM)13.07
Forward P/E7.60
Price to Sales (P/S)1.98
Price to Book (P/B)1.99
EV/EBITDA9.48
Revenue (TTM)22.03B
Net Income (TTM)3.33B
Free Cash Flow (TTM)4.60B
EPS (TTM)$0.74
Profit Margin15.11%
Operating Margin22.16%
Return on Equity (ROE)15.22%
Debt to Equity0.53
50-Day MA$9.32
200-Day MA$9.75
52-Week Change-0.41%
Annual Dividend$0.31
Dividend Yield3.16%
Payout Ratio41.59%
Last Dividend Ex-DateMay 14, 2027

Frequently Asked Questions About Haleon

What is the current stock price for HLN?

As of the latest trading session, HLN stock trades at $9.71. The 52-week range is $8.65–$11.28, with a day range of $9.63–$9.73.

What is the P/E ratio for HLN?

Haleon's trailing P/E ratio is 13.1, meaning investors pay $13.1 for every $1 of annual earnings. The forward P/E is 7.6, reflecting analyst expectations for future earnings. Haleon operates in the Healthcare sector.

Does HLN pay dividends?

Yes, Haleon pays a 3.16% annual dividend yield ($0.31 per share). The payout ratio is 41.6%. The last ex-dividend date was 2027-05-14.

What do analysts recommend for HLN?

Analyst ratings and recommendations for HLN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of HLN?

Haleon's market capitalization is $43.51B, classifying it as a large-cap company. Haleon operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.